Multiple-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double-Blind Study. - Hussey,EK.; Dobbins,RL.; Stoltz,RR. (J Clin Pharmacol, 2010)